Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2007, Vol. 109, No. 2, pp. 595-602.
Prepublished online as a Blood First Edition Paper on September 19, 2006; DOI 10.1182/blood-2005-11-011775.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2005-11-011775v1
109/2/595    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van de Walle, G. R
Right arrow Articles by Deckmyn, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van de Walle, G. R
Right arrow Articles by Deckmyn, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 30, 2005
Accepted August 18, 2006

Activation of {alpha}IIb{beta}3 is a sufficient but also an imperative prerequisite to activate {alpha}2{beta}1 on platelets

Gerlinde R Van de Walle, Anne Schoolmeester, Brecht F Iserbyt, Judith M.E.M. Cosemans, Johan W.M. Heemskerk, Marc F. Hoylaerts, Alan Nurden, Karen Vanhoorelbeke, and Hans Deckmyn*

Laboratory for Thrombosis Research, K.U. Leuven Campus Kortrijk, Kortrijk, Belgium
Departments of Biochemistry and Human Biology, CARIM, Maastricht University, The Netherlands
Center for Molecular and Vascular Biology, K.U. Leuven, Leuven, Belgium
Institut Federatif #4, Hopital Cardiologique, Pessac, France

* Corresponding author; email: hans.deckmyn{at}kulak.ac.be.

Platelet integrins {alpha}2{beta}1 and {alpha}IIb{beta}3 play critical roles in platelet adhesion and thrombus formation after vascular injury. On resting platelets, both integrins are in a low affinity state. However, agonist stimulation results in conformational changes that enable ligand binding that can be detected with conformation dependent monoclonal antibodies (mAbs). By using such conformation dependent mAbs, we could demonstrate that activation of integrin {alpha}IIb{beta}3 is not only sufficient, but also a prerequisite for {alpha}2{beta}1 activation. Compared to platelets in plasma, stimulation of washed platelets resulted in only a minor activation of {alpha}2{beta}1, as detected with the activation-sensitive mAb IAC-1. Addition of fibrinogen to stimulated washed platelets greatly potentiated activation of this integrin. Also, treatment of {alpha}IIb{beta}3 with the ligand-mimetic peptide RGDS, resulting in outside-in signaling, led to a powerful {alpha}2{beta}1 activation, even in the absence of overall platelet activation, involving tyrosine kinase activity but no protein kinase C activation. The absolute necessity of {alpha}IIb{beta}3 for proper {alpha}2{beta}1 activation on platelets was demonstrated by using the {alpha}IIb{beta}3 antagonist aggrastat, which was able to completely abolish {alpha}2{beta}1 activation, both under static and flow conditions. Additionally, analogous experiments with Glanzmann platelets, lacking {alpha}IIb{beta}3, confirmed the indispensability of {alpha}IIb{beta}3 for {alpha}2{beta}1 activation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. Mazzucato, M. R. Cozzi, M. Battiston, M. Jandrot-Perrus, M. Mongiat, P. Marchese, T. J. Kunicki, Z. M. Ruggeri, and L. De Marco
Distinct spatio-temporal Ca2+ signaling elicited by integrin {alpha}2{beta}1 and glycoprotein VI under flow
Blood, September 24, 2009; 114(13): 2793 - 2801.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
J. Rivera, M. L. Lozano, L. Navarro-Nunez, and V. Vicente
Platelet receptors and signaling in the dynamics of thrombus formation
Haematologica, May 1, 2009; 94(5): 700 - 711.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Prevost, J. V. Mitsios, H. Kato, J. E. Burke, E. A. Dennis, T. Shimizu, and S. J. Shattil
Group IVA cytosolic phospholipase A2 (cPLA2{alpha}) and integrin {alpha}IIb{beta}3 reinforce each other's functions during {alpha}IIb{beta}3 signaling in platelets
Blood, January 8, 2009; 113(2): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Varga-Szabo, I. Pleines, and B. Nieswandt
Cell Adhesion Mechanisms in Platelets
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 403 - 412.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020